775
vs
H
Hang Seng (Hong Kong)
775
Over the past 12 months, CK Life Sciences Intl (Holdings) Inc has significantly outperformed Hang Seng (Hong Kong), delivering a return of +70% compared to the Hang Seng (Hong Kong)'s +16% growth.
Stocks Performance
775 vs Hang Seng (Hong Kong)
Performance Gap
775 vs Hang Seng (Hong Kong)
Performance By Year
775 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CK Life Sciences Intl (Holdings) Inc
Glance View
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. The company employs 1,855 full-time employees The company went IPO on 2002-07-16. The firm operates through three segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others. The Investment segment is engaged in the investment in financial and investment products.
